Omalizumab Blog

Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study

Posted 16 Mar 2011 by Drugs.com

WEDNESDAY, March 16 – The injectable medication Xolair reduced asthma symptoms in inner city children with the respiratory condition, and almost eliminated seasonal peaks in asthma attacks, new research shows. When added to standard asthma treatments, Xolair (omalizumab) decreased the amount of inhaled steroid needed to maintain asthma control, according to the study, which is published in the March 17 issue of the New England Journal of Medicine. "Omalizumab improves asthma control on top of guidelines-based treatment," said study co-author Dr. William Busse, a professor of medicine at the University of Wisconsin School of Medicine in Madison. "There was less need for other medications, a reduction of symptoms and reduction of the seasonal exacerbations of asthma. Omalizumab almost totally eliminated these attacks." But, he added, it's too soon to make treatment recommendations based ... Read more

Related support groups: Asthma, Xolair, Omalizumab